{"organizations": [], "uuid": "6dc0a65205800c74ced6e3166096f2981b18ad6f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/08/globe-newswire-cv-sciences-inc-to-host-first-quarter-2018-financial-results-conference-call-on-tuesday-may-15-2018.html", "country": "US", "domain_rank": 767, "title": "CV Sciences, Inc. to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-05-08T13:45:00.000+03:00", "replies_count": 0, "uuid": "6dc0a65205800c74ced6e3166096f2981b18ad6f"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/08/globe-newswire-cv-sciences-inc-to-host-first-quarter-2018-financial-results-conference-call-on-tuesday-may-15-2018.html", "ord_in_thread": 0, "title": "CV Sciences, Inc. to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018", "locations": [], "entities": {"persons": [{"name": "joseph dowling", "sentiment": "none"}], "locations": [{"name": "las vegas", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}], "organizations": [{"name": "cvsi", "sentiment": "negative"}, {"name": "cv sciences, inc.", "sentiment": "neutral"}, {"name": "cv sciences", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "LAS VEGAS, May 08, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI) a preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, today announced that it is scheduled to host a conference call to discuss its first quarter 2018 financial results on Tuesday, May 15, 2018 at 1:15pm PT / 4:15pm ET.\nCV Sciences’ CFO Joseph Dowling will lead the call to provide an operational and financial summary of the first quarter ended March 31, 2018. Interested parties may access the live webcast by visiting: https://78449.themediaframe.com/dataconf/productusers/cvsciences/mediaframe/24633/indexl.html\nIn order to ensure adequate time for any software downloads that may be necessary to listen to the webcast, attendees are encouraged to connect to the website 10-15 minutes prior to the live event.\nParticipants may also access the listen-only audio call by dialing 1-877-407-8293 (United States) or 1-201-689-8349 (International). If you are unable to participate in the call at this time, a replay will be available for 14 days starting on May 15, 2018, at approximately 7:30 p.m. PT/10:30 p.m. ET. To access the replay, please dial 1-877-660-6853 in the U.S. and 1-201-612-7415 for international callers. The conference ID# is 13679917.\nAbout CV Sciences, Inc.\nCV Sciences, Inc (OTCQB:CVSI), located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. Additional information is available from OTCMarkets.com or by visiting PlusCBDoil.com .\nFORWARD-LOOKING DISCLAIMER\nThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.\nCONTACT INFORMATION:\nRobert Haag\nManaging Director\nIRTH Communications\nCVSI@irthcommunications.com\n866-976-4784\nSource:CV Sciences, Inc.", "external_links": ["https://www.globenewswire.com/Tracker?data=RJhuisws2hwxsIjBjgRXk7yCLZbFxnhruVnGjM3gWc8cwbKE1gjfTPpW9dMBe3F4XIwwnAF6fJh5LbKhpd-0VH5Lr-28rUh_Kk0rZQk2-eoZLJCU-eOD1TnkaCipllBMwlDLnOp-C0o0ltKOE81P22kRGQcZsB4cSDIMFe_i8bCY8qUeBWK5zko63Ko-KKEcabYjCCwwfLmFsscsEKEPDNivTuvhDATFBDmupXfs78R5MYAslsviQroTWwr-pYbT3Fg1ElHWKjU4cAUQw0Oj-Q==", "https://www.globenewswire.com/Tracker?data=r166XeUPKWJknzBFJM_L65lPLf4JMlPwOyywJP5Y2BZejxk9FFZTchzs1i6qAhhX1fPZC0B252K7Sc3w44CyKcRCMDYcSpa8G-ORECrjtW9ovI3aTSv45LvpmEAl5LPj5nB6U3j0zTYIokPIniEIqPzkf4xif7FH249v3csEck9yUCYHhl67evLuH-hgziBAuG9cLu2EKjwOXASFbv4FqJix556lDeHg5JYyjsfpZcq8-6-DfOwGGCYiRpWvgD42", "https://78449.themediaframe.com/dataconf/productusers/cvsciences/mediaframe/24633/indexl.html", "https://www.globenewswire.com/Tracker?data=WYKHi62499Oit_v2ItsGB0XwbD5thFMAYWG9xrtiLkoDriQJDe3g0fKqomls3Y65WxljcI_XNWL6gF9wCzX-t4oR7iYimDE_3Buq6xqV4eLdvvwj3QxMrdc71DSZaUfz", "https://www.globenewswire.com/NewsRoom/AttachmentNg/f60dedb9-b1f3-4503-afba-013d13ba0b53", "https://www.globenewswire.com/Tracker?data=9Uj3GhL4g97tDgkTse-VbHG_UmtnR1p5rrqHpWE_-_kfBpfZKcVkiwJWwdm6S2Xdk11BpK5VwOd9C8woueeJSQ=="], "published": "2018-05-08T13:45:00.000+03:00", "crawled": "2018-05-08T14:35:14.001+03:00", "highlightTitle": ""}